| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 4.54e-08 | 11 | 203 | 5 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.66e-05 | 32 | 203 | 5 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 5.59e-05 | 130 | 203 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 6.48e-05 | 42 | 203 | 5 | GO:0098918 | |
| GeneOntologyBiologicalProcess | neuron projection development | TANC2 ERCC6 KIF1A ACTBL2 SARM1 ACTB ACTG1 CDH23 CHAT POTEKP GFI1 HOXA2 HMCN2 STK24 ALK PLXNB1 HSPG2 FAT4 NPR2 FN1 ANK3 ADAMTS1 POTEF APC SHOC2 NPTN ARSB MEGF8 DOCK7 LRP1 TRAK2 | 1.94e-06 | 1285 | 198 | 31 | GO:0031175 |
| GeneOntologyBiologicalProcess | condensed mesenchymal cell proliferation | 3.46e-06 | 4 | 198 | 3 | GO:0072137 | |
| GeneOntologyBiologicalProcess | neuron development | TANC2 ERCC6 KIF1A ACTBL2 SARM1 ACTB ACTG1 CDH23 CHAT POTEKP GFI1 HOXA2 HMCN2 KCNB1 STK24 ALK PLXNB1 HSPG2 FAT4 NPR2 FN1 ANK3 ADAMTS1 POTEF APC SHOC2 NPTN ARSB MEGF8 DOCK7 LRP1 TRAK2 | 9.98e-06 | 1463 | 198 | 32 | GO:0048666 |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 1.07e-05 | 31 | 198 | 5 | GO:0098974 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TANC2 KIF1A ACTBL2 SARM1 ACTB ACTG1 CDH23 POTEKP HOXA2 HMCN2 PLXNB1 HSPG2 NPR2 FN1 ANK3 POTEF APC MEGF8 DOCK7 LRP1 TRAK2 | 1.12e-05 | 748 | 198 | 21 | GO:0048667 |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 1.99e-05 | 35 | 198 | 5 | GO:0099188 | |
| GeneOntologyBiologicalProcess | positive regulation of protein targeting to membrane | 1.99e-05 | 35 | 198 | 5 | GO:0090314 | |
| GeneOntologyBiologicalProcess | cell junction organization | TANC2 KIF1A ACTBL2 SARM1 INSR ACTB ACTG1 CHAT POTEKP HMCN2 PLXNB1 FN1 ANK3 POTEF PKP4 APC GRM6 TGFB1 NPTN DOCK7 LRP1 ELAVL2 LRP5 TANC1 | 2.24e-05 | 974 | 198 | 24 | GO:0034330 |
| GeneOntologyBiologicalProcess | axonogenesis | ACTBL2 ACTB ACTG1 POTEKP HOXA2 HMCN2 PLXNB1 HSPG2 NPR2 FN1 ANK3 POTEF APC MEGF8 DOCK7 LRP1 TRAK2 | 3.48e-05 | 566 | 198 | 17 | GO:0007409 |
| GeneOntologyBiologicalProcess | synapse organization | TANC2 KIF1A ACTBL2 SARM1 INSR ACTB ACTG1 CHAT POTEKP HMCN2 PLXNB1 ANK3 POTEF GRM6 NPTN DOCK7 ELAVL2 LRP5 TANC1 | 3.54e-05 | 685 | 198 | 19 | GO:0050808 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to membrane | 3.74e-05 | 130 | 198 | 8 | GO:1905477 | |
| GeneOntologyBiologicalProcess | axon development | ACTBL2 ACTB ACTG1 POTEKP HOXA2 HMCN2 STK24 PLXNB1 HSPG2 NPR2 FN1 ANK3 POTEF APC MEGF8 DOCK7 LRP1 TRAK2 | 4.99e-05 | 642 | 198 | 18 | GO:0061564 |
| GeneOntologyBiologicalProcess | regulation of protein targeting to membrane | 5.55e-05 | 43 | 198 | 5 | GO:0090313 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TANC2 KIF1A ACTBL2 SARM1 ACTB ACTG1 POTEKP HOXA2 HMCN2 PLXNB1 HSPG2 NPR2 FN1 ANK3 POTEF APC MEGF8 DOCK7 LRP1 TRAK2 | 9.57e-05 | 802 | 198 | 20 | GO:0048812 |
| GeneOntologyBiologicalProcess | negative regulation of catalytic activity | SERPINB7 ACTB INTS1 GAS6 ANGPTL8 GFI1 SERPINB8 SERPINB9 QARS1 PIF1 COL7A1 APC APBA3 PI15 GSTP1 LRP1 LRP5 | 9.65e-05 | 615 | 198 | 17 | GO:0043086 |
| GeneOntologyBiologicalProcess | negative regulation of stress-activated protein kinase signaling cascade | 9.95e-05 | 10 | 198 | 3 | GO:0070303 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to membrane | 1.02e-04 | 237 | 198 | 10 | GO:1905475 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TANC2 KIF1A ACTBL2 SARM1 ACTB ACTG1 POTEKP HOXA2 HMCN2 PLXNB1 HSPG2 NPR2 FN1 ANK3 POTEF APC MEGF8 DOCK7 LRP1 TRAK2 | 1.27e-04 | 819 | 198 | 20 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TANC2 KIF1A ACTBL2 SARM1 ACTB ACTG1 POTEKP HOXA2 HMCN2 PLXNB1 HSPG2 NPR2 FN1 ANK3 POTEF APC MEGF8 DOCK7 LRP1 TRAK2 | 1.42e-04 | 826 | 198 | 20 | GO:0048858 |
| GeneOntologyBiologicalProcess | response to wounding | ERBB3 SARM1 ACTB CELA2A GAS6 ACTG1 F12 KCNB1 SYK STK24 TRIM72 NPR2 FN1 DUOX2 NMNAT3 TGFB1 LRP1 | 2.19e-04 | 659 | 198 | 17 | GO:0009611 |
| GeneOntologyBiologicalProcess | postsynapse organization | TANC2 KIF1A ACTBL2 INSR ACTB ACTG1 POTEKP POTEF DOCK7 LRP5 TANC1 | 2.31e-04 | 313 | 198 | 11 | GO:0099173 |
| GeneOntologyBiologicalProcess | heme transmembrane transport | 2.73e-04 | 3 | 198 | 2 | GO:0035351 | |
| GeneOntologyBiologicalProcess | regulation of protein targeting | 2.76e-04 | 93 | 198 | 6 | GO:1903533 | |
| GeneOntologyCellularComponent | axon | IGSF8 TANC2 KIF1A ACTBL2 SARM1 INSR ACTB ACTG1 CHAT POTEKP HMCN2 KCNB1 ALK AMFR ANK3 POTEF APC NMNAT3 TGFB1 P2RX3 IGHMBP2 SBF2 CPEB4 DOCK7 LRP1 TANC1 TRAK2 | 1.31e-07 | 891 | 201 | 27 | GO:0030424 |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 1.27e-05 | 32 | 201 | 5 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 1.27e-05 | 32 | 201 | 5 | GO:0043189 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 6.99e-05 | 45 | 201 | 5 | GO:1902562 | |
| GeneOntologyCellularComponent | basement membrane | 1.80e-04 | 122 | 201 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | THSD4 CELA2A F12 FREM2 SERPINB8 SERPINB9 HMCN2 HSPG2 COL7A1 COL8A1 FN1 ADAMTS1 ITLN1 TGFB1 VWA5A | 1.98e-04 | 530 | 201 | 15 | GO:0062023 |
| GeneOntologyCellularComponent | apical part of cell | GABRP ERBB3 ATP7B MYO7B ACTG1 CDH23 SLC22A7 SPTBN5 KCNB1 KCNN4 FAT4 FN1 ABCC5 DUOX2 DCHS1 LRP1 | 2.05e-04 | 592 | 201 | 16 | GO:0045177 |
| GeneOntologyCellularComponent | somatodendritic compartment | TANC2 KIF1A SARM1 INSR CHAT HMCN2 KCNB1 RPTOR XRN1 KCNN4 AMFR ANK3 ZDHHC5 APC APBA3 GRM6 NMNAT3 TGFB1 NPTN P2RX3 IGHMBP2 CPEB4 LRP1 TANC1 TRAK2 | 3.22e-04 | 1228 | 201 | 25 | GO:0036477 |
| GeneOntologyCellularComponent | receptor complex | GABRP ERBB3 INSR ITGAX LRP1B ADCYAP1R1 SYK ALK PLXNB1 ITLN1 MST1R P2RX3 MTTP LRP1 LRP5 | 5.23e-04 | 581 | 201 | 15 | GO:0043235 |
| GeneOntologyCellularComponent | extracellular matrix | THSD4 CELA2A F12 FREM2 SERPINB8 SERPINB9 HMCN2 GPLD1 HSPG2 COL7A1 COL8A1 FN1 ADAMTS1 ITLN1 TGFB1 VWA5A | 6.32e-04 | 656 | 201 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | dendrite | TANC2 KIF1A SARM1 INSR KCNB1 RPTOR XRN1 AMFR ANK3 ZDHHC5 APC APBA3 GRM6 NPTN P2RX3 CPEB4 LRP1 TANC1 TRAK2 | 6.46e-04 | 858 | 201 | 19 | GO:0030425 |
| GeneOntologyCellularComponent | external encapsulating structure | THSD4 CELA2A F12 FREM2 SERPINB8 SERPINB9 HMCN2 GPLD1 HSPG2 COL7A1 COL8A1 FN1 ADAMTS1 ITLN1 TGFB1 VWA5A | 6.53e-04 | 658 | 201 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | dendritic tree | TANC2 KIF1A SARM1 INSR KCNB1 RPTOR XRN1 AMFR ANK3 ZDHHC5 APC APBA3 GRM6 NPTN P2RX3 CPEB4 LRP1 TANC1 TRAK2 | 6.64e-04 | 860 | 201 | 19 | GO:0097447 |
| GeneOntologyCellularComponent | polar microtubule | 9.03e-04 | 5 | 201 | 2 | GO:0005827 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.11e-03 | 320 | 201 | 10 | GO:0016323 | |
| GeneOntologyCellularComponent | basal part of cell | ERBB3 ATP7B SLC22A7 KCNN4 ABCC10 CA11 ANK3 ABCC5 DOCK7 MTTP LRP1 | 1.13e-03 | 378 | 201 | 11 | GO:0045178 |
| GeneOntologyCellularComponent | cell body | KIF1A INSR ACTG2 CHAT HMCN2 KCNB1 RPTOR XRN1 KCNN4 ALK AMFR APC NMNAT3 TGFB1 P2RX3 IGHMBP2 LRP1 TANC1 TRAK2 | 1.63e-03 | 929 | 201 | 19 | GO:0044297 |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.77e-03 | 90 | 201 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | dense body | 1.87e-03 | 7 | 201 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 2.15e-03 | 94 | 201 | 5 | GO:0000123 | |
| MousePheno | abnormal Schwann cell morphology | 4.70e-06 | 37 | 168 | 6 | MP:0001106 | |
| MousePheno | abnormal PNS glial cell morphology | 4.70e-06 | 37 | 168 | 6 | MP:0001105 | |
| MousePheno | abnormal cochlea morphology | ERCC6 ACTB ACTG1 CDH23 GFI1 HOXA2 HOXB2 FAT4 DUOX2 IDUA NPTN DCHS1 | 4.56e-05 | 248 | 168 | 12 | MP:0000031 |
| MousePheno | abnormal inner ear morphology | ERCC6 ACTB ACTG1 CDH23 GFI1 HOXA2 HOXB2 HSPG2 FAT4 DUOX2 IDUA NPTN DCHS1 | 7.57e-05 | 303 | 168 | 13 | MP:0000026 |
| MousePheno | increased large intestine adenocarcinoma incidence | 9.13e-05 | 8 | 168 | 3 | MP:0009310 | |
| MousePheno | abnormal cochlear labyrinth morphology | ERCC6 ACTB ACTG1 CDH23 GFI1 HOXB2 FAT4 DUOX2 IDUA NPTN DCHS1 | 1.28e-04 | 235 | 168 | 11 | MP:0004426 |
| MousePheno | abnormal scala media morphology | ERCC6 ACTB ACTG1 CDH23 GFI1 HOXB2 FAT4 DUOX2 IDUA NPTN DCHS1 | 1.28e-04 | 235 | 168 | 11 | MP:0003169 |
| MousePheno | abnormal heart valve morphology | 1.55e-04 | 163 | 168 | 9 | MP:0000285 | |
| MousePheno | abnormal cochlear hair cell morphology | 1.65e-04 | 202 | 168 | 10 | MP:0002622 | |
| MousePheno | abnormal ear morphology | ERCC6 ACTB ACTG1 CDH23 GFI1 HOXA2 HOXB2 FREM2 PGAP1 HSPG2 FAT4 DUOX2 IDUA NPTN SLC25A1 DCHS1 | 1.74e-04 | 470 | 168 | 16 | MP:0002102 |
| MousePheno | abnormal atrioventricular valve morphology | 1.77e-04 | 69 | 168 | 6 | MP:0002745 | |
| MousePheno | abnormal cochlear sensory epithelium morphology | 2.01e-04 | 207 | 168 | 10 | MP:0003308 | |
| MousePheno | hearing/vestibular/ear phenotype | ERCC6 KIF1A ACTB ACTG1 CDH23 GFI1 HOXA2 SPTBN5 HOXB2 FREM2 SERPINB9 PGAP1 MYO18B DNAH5 HSPG2 FAT4 ZDHHC5 DUOX2 IDUA NPTN ARSB PCNX4 SLC25A1 DCHS1 | 2.08e-04 | 905 | 168 | 24 | MP:0005377 |
| MousePheno | abnormal organ of Corti morphology | 2.17e-04 | 209 | 168 | 10 | MP:0000042 | |
| Domain | Actin_CS | 5.19e-07 | 16 | 199 | 5 | IPR004001 | |
| Domain | ACTINS_2 | 7.28e-07 | 17 | 199 | 5 | PS00432 | |
| Domain | Actin | 8.00e-07 | 31 | 199 | 6 | IPR004000 | |
| Domain | Actin | 8.00e-07 | 31 | 199 | 6 | PF00022 | |
| Domain | ACTIN | 8.00e-07 | 31 | 199 | 6 | SM00268 | |
| Domain | ACTINS_1 | 8.47e-07 | 8 | 199 | 4 | PS00406 | |
| Domain | Actin/actin-like_CS | 1.00e-06 | 18 | 199 | 5 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 1.34e-06 | 19 | 199 | 5 | PS01132 | |
| Domain | EGF-like_Ca-bd_dom | 7.29e-06 | 124 | 199 | 9 | IPR001881 | |
| Domain | LDLRA_1 | 1.15e-05 | 48 | 199 | 6 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 1.30e-05 | 49 | 199 | 6 | IPR002172 | |
| Domain | LDLa | 1.30e-05 | 49 | 199 | 6 | SM00192 | |
| Domain | LDLRA_2 | 1.30e-05 | 49 | 199 | 6 | PS50068 | |
| Domain | Growth_fac_rcpt_ | 4.57e-05 | 156 | 199 | 9 | IPR009030 | |
| Domain | EGF_CA | 4.92e-05 | 122 | 199 | 8 | SM00179 | |
| Domain | LDLR_class-A_CS | 6.35e-05 | 40 | 199 | 5 | IPR023415 | |
| Domain | EGF_CA | 9.13e-05 | 99 | 199 | 7 | PS01187 | |
| Domain | EGF_1 | 9.50e-05 | 255 | 199 | 11 | PS00022 | |
| Domain | Keratin_2_head | 1.12e-04 | 24 | 199 | 4 | IPR032444 | |
| Domain | Keratin_2_head | 1.12e-04 | 24 | 199 | 4 | PF16208 | |
| Domain | Ldl_recept_a | 1.13e-04 | 45 | 199 | 5 | PF00057 | |
| Domain | tRNA-synt_1c_C | 1.13e-04 | 2 | 199 | 2 | PF03950 | |
| Domain | M60-like | 1.13e-04 | 2 | 199 | 2 | SM01276 | |
| Domain | Ribosomal_L25/Gln-tRNA_synth | 1.13e-04 | 2 | 199 | 2 | IPR011035 | |
| Domain | - | 1.13e-04 | 2 | 199 | 2 | 2.40.240.10 | |
| Domain | Rbsml_L25/Gln-tRNA_synth_b-brl | 1.13e-04 | 2 | 199 | 2 | IPR020056 | |
| Domain | Glu/Gln-tRNA-synth_Ib_codon-bd | 1.13e-04 | 2 | 199 | 2 | IPR020059 | |
| Domain | Peptidase_M60_dom | 1.13e-04 | 2 | 199 | 2 | IPR031161 | |
| Domain | DUF5050 | 1.13e-04 | 2 | 199 | 2 | IPR032485 | |
| Domain | Peptidase_M60 | 1.13e-04 | 2 | 199 | 2 | PF13402 | |
| Domain | DUF5050 | 1.13e-04 | 2 | 199 | 2 | PF16472 | |
| Domain | PEPTIDASE_M60 | 1.13e-04 | 2 | 199 | 2 | PS51723 | |
| Domain | EGF-like_CS | 1.17e-04 | 261 | 199 | 11 | IPR013032 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.17e-04 | 138 | 199 | 8 | IPR001245 | |
| Domain | - | 1.26e-04 | 46 | 199 | 5 | 4.10.400.10 | |
| Domain | Keratin_II | 1.56e-04 | 26 | 199 | 4 | IPR003054 | |
| Domain | EGF_3 | 2.21e-04 | 235 | 199 | 10 | PS50026 | |
| Domain | EGF_CA | 3.14e-04 | 86 | 199 | 6 | PF07645 | |
| Domain | tRNA-synt_1c | 3.36e-04 | 3 | 199 | 2 | PF00749 | |
| Domain | Glu/Gln-tRNA-synth_Ib_a-bdl | 3.36e-04 | 3 | 199 | 2 | IPR020061 | |
| Domain | - | 3.36e-04 | 3 | 199 | 2 | 1.10.1160.10 | |
| Domain | Glu/Gln-tRNA-synth_Ib_cat-dom | 3.36e-04 | 3 | 199 | 2 | IPR020058 | |
| Domain | SBF2 | 3.36e-04 | 3 | 199 | 2 | PF12335 | |
| Domain | Glu/Gln-tRNA-synth | 3.36e-04 | 3 | 199 | 2 | IPR000924 | |
| Domain | SBF1/SBF2 | 3.36e-04 | 3 | 199 | 2 | IPR022096 | |
| Domain | EGF-like_dom | 3.50e-04 | 249 | 199 | 10 | IPR000742 | |
| Domain | PP2C_SIG | 3.98e-04 | 14 | 199 | 3 | SM00331 | |
| Domain | Ldl_recept_b | 3.98e-04 | 14 | 199 | 3 | PF00058 | |
| Domain | LDLRB | 3.98e-04 | 14 | 199 | 3 | PS51120 | |
| Domain | Pkinase_Tyr | 4.69e-04 | 129 | 199 | 7 | PF07714 | |
| Domain | TPR | 4.69e-04 | 129 | 199 | 7 | SM00028 | |
| Domain | LY | 4.93e-04 | 15 | 199 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 4.93e-04 | 15 | 199 | 3 | IPR000033 | |
| Domain | TPR_repeat | 5.63e-04 | 133 | 199 | 7 | IPR019734 | |
| Domain | EGF_2 | 5.70e-04 | 265 | 199 | 10 | PS01186 | |
| Domain | EGF_Ca-bd_CS | 6.00e-04 | 97 | 199 | 6 | IPR018097 | |
| Domain | FN1_2 | 6.68e-04 | 4 | 199 | 2 | PS51091 | |
| Domain | ELAD_HUD_SF | 6.68e-04 | 4 | 199 | 2 | IPR006548 | |
| Domain | Serpin_B9/Maspin | 6.68e-04 | 4 | 199 | 2 | IPR000240 | |
| Domain | fn1 | 6.68e-04 | 4 | 199 | 2 | PF00039 | |
| Domain | Fibronectin_type1 | 6.68e-04 | 4 | 199 | 2 | IPR000083 | |
| Domain | FN1 | 6.68e-04 | 4 | 199 | 2 | SM00058 | |
| Domain | FN1_1 | 6.68e-04 | 4 | 199 | 2 | PS01253 | |
| Domain | ASX_HYDROXYL | 7.05e-04 | 100 | 199 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.57e-04 | 106 | 199 | 6 | IPR000152 | |
| Domain | TPR-contain_dom | 1.14e-03 | 150 | 199 | 7 | IPR013026 | |
| Domain | PP2Cc | 1.19e-03 | 20 | 199 | 3 | SM00332 | |
| Domain | - | 1.19e-03 | 20 | 199 | 3 | 3.60.40.10 | |
| Domain | PPM-type_phosphatase_dom | 1.19e-03 | 20 | 199 | 3 | IPR001932 | |
| Domain | PPM_2 | 1.19e-03 | 20 | 199 | 3 | PS51746 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.44e-03 | 46 | 199 | 4 | IPR011042 | |
| Domain | TPR_REGION | 1.98e-03 | 165 | 199 | 7 | PS50293 | |
| Domain | TPR | 1.98e-03 | 165 | 199 | 7 | PS50005 | |
| Domain | Recep_L_domain | 2.29e-03 | 7 | 199 | 2 | PF01030 | |
| Domain | Furin-like | 2.29e-03 | 7 | 199 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 2.29e-03 | 7 | 199 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 2.29e-03 | 7 | 199 | 2 | IPR006211 | |
| Domain | - | 2.29e-03 | 7 | 199 | 2 | 3.80.20.20 | |
| Domain | EGF | 2.32e-03 | 126 | 199 | 6 | PF00008 | |
| Domain | TPR_8 | 2.44e-03 | 53 | 199 | 4 | PF13181 | |
| Domain | Tyr_kinase_cat_dom | 2.50e-03 | 88 | 199 | 5 | IPR020635 | |
| Domain | TyrKc | 2.50e-03 | 88 | 199 | 5 | SM00219 | |
| Domain | cEGF | 2.59e-03 | 26 | 199 | 3 | PF12662 | |
| Domain | cEGF | 2.59e-03 | 26 | 199 | 3 | IPR026823 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MAN2A1 KRT74 ACTB GAS6 GATM ACTG1 ACTG2 POTEKP F12 KRT73 FREM2 FASN CILP2 SERPINB8 SERPINB9 KRT71 C6 STK24 DPP7 GPLD1 HSPG2 FAT4 FN1 POTEF IDUA PI15 GSTP1 ARSB MEGF8 | 6.80e-12 | 1070 | 203 | 29 | 23533145 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 ZXDC SDSL SPHK2 INTS1 PER1 KMT2C FASN SBF1 FAM83F KLHL21 RPTOR ABCD1 IQGAP3 ABCC10 HSPG2 POLE AOC2 ZDHHC5 HUWE1 IDUA MST1R MEGF8 PCNX4 SBF2 LRP5 TANC1 SLC45A1 | 7.65e-11 | 1105 | 203 | 28 | 35748872 |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 1.76e-10 | 15 | 203 | 6 | 16824795 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 4.45e-10 | 101 | 203 | 10 | 23382219 | |
| Pubmed | MAN2A1 F12 FREM2 C6 PLXNB1 CA11 GPLD1 HSPG2 FN1 TGFB1 MEGF8 LRP1 | 4.33e-08 | 257 | 203 | 12 | 16335952 | |
| Pubmed | 6.18e-08 | 36 | 203 | 6 | 9344654 | ||
| Pubmed | IGSF8 TANC2 SART3 EPRS1 ACTBL2 ACTB ACTG1 CSDE1 FASN SBF1 RPTOR XRN1 SLC25A11 SLC39A7 KRT5 FN1 ANK3 PKP4 APC GSTP1 PACS1 NPTN P2RX3 CPEB4 DOCK7 ELAVL3 TANC1 | 8.61e-08 | 1431 | 203 | 27 | 37142655 | |
| Pubmed | SART3 EPRS1 ERBB3 CSDE1 FREM2 SBF1 TONSL XRN1 SLC25A11 IQGAP3 PLXNB1 POLE PKP4 APC PACS1 DOCK7 TANC1 | 3.22e-07 | 650 | 203 | 17 | 38777146 | |
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | 4.94e-07 | 210 | 203 | 10 | 26217791 | |
| Pubmed | TANC2 ERCC6 ATP7B ATAD5 GAS6 PER1 HMCN2 KLHL21 RPTOR XRN1 PEX5 SLC25A11 AGBL1 SLC39A7 ADAMTS1 PKP4 TTC7A ARSB CPEB4 LRP1 TANC1 ALG13 | 7.24e-07 | 1116 | 203 | 22 | 31753913 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | IGSF8 EPRS1 TCAF1 KIF1A SARM1 TEX10 CSDE1 FASN RPTOR ABCD1 QARS1 IQGAP3 AMFR ADAMTS1 POLE NUP88 LMBR1 HUWE1 NPTN SLC25A1 | 7.70e-07 | 942 | 203 | 20 | 31073040 |
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 9182575 | ||
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 12648212 | ||
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 20976199 | ||
| Pubmed | 1.04e-06 | 57 | 203 | 6 | 31862882 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 EPRS1 ERCC6 ACTB MAP3K20 TEX10 CSDE1 FASN ADPRS SBF1 RPTOR XRN1 SLC25A11 QARS1 COL8A1 FN1 PMPCB POLE PKP4 HUWE1 GSTP1 SLC25A1 CSTF1 TANC1 | 1.42e-06 | 1353 | 203 | 24 | 29467282 |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | SART3 SERPINB7 EPRS1 SERPINB8 XRN1 SLC25A11 QARS1 PTBP3 KRT5 COL8A1 PKP4 KLHL22 TGFB1 GSTP1 SLC25A1 RBFOX1 DOCK7 | 1.64e-06 | 732 | 203 | 17 | 34732716 |
| Pubmed | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. | 1.91e-06 | 141 | 203 | 8 | 32322062 | |
| Pubmed | 1.94e-06 | 5 | 203 | 3 | 17554369 | ||
| Pubmed | Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1. | 1.94e-06 | 5 | 203 | 3 | 16061471 | |
| Pubmed | ERCC6 ACTBL2 ACTB ACTG1 ACTG2 POTEKP KLHL21 XRN1 SLC25A11 STK24 FAT4 POTEF PPM1B TRAK2 | 2.23e-06 | 513 | 203 | 14 | 25798074 | |
| Pubmed | 2.48e-06 | 251 | 203 | 10 | 29031500 | ||
| Pubmed | 2.53e-06 | 17 | 203 | 4 | 8997639 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.21e-06 | 202 | 203 | 9 | 33005030 | |
| Pubmed | 3.21e-06 | 202 | 203 | 9 | 24639526 | ||
| Pubmed | IGSF8 EPRS1 ACTG1 FASN CILP2 SLC25A11 DPP7 HSPG2 HUWE1 PPM1B TGFB1 NPTN MEGF8 SLC25A1 LRP1 | 3.65e-06 | 613 | 203 | 15 | 22268729 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | SART3 TCAF1 KIF1A INTS1 CSDE1 XRN1 FN1 PKP4 PACS1 CPEB4 RBFOX1 ELAVL2 ELAVL3 | 3.73e-06 | 462 | 203 | 13 | 31138677 |
| Pubmed | TANC2 DOCK4 SART3 EPRS1 PER1 LRP1B CSDE1 KCNB1 RPTOR XRN1 SLC25A11 SLC39A7 ANK3 NUP88 APC HUWE1 SHOC2 GUCY1B1 IGHMBP2 CPEB4 DOCK7 | 3.73e-06 | 1139 | 203 | 21 | 36417873 | |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 3.87e-06 | 6 | 203 | 3 | 22989508 | |
| Pubmed | 3.87e-06 | 6 | 203 | 3 | 8761950 | ||
| Pubmed | 3.87e-06 | 6 | 203 | 3 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 3.87e-06 | 6 | 203 | 3 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 3.87e-06 | 6 | 203 | 3 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 3.87e-06 | 6 | 203 | 3 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 3.87e-06 | 6 | 203 | 3 | 8661406 | |
| Pubmed | 3.87e-06 | 6 | 203 | 3 | 23017337 | ||
| Pubmed | 3.87e-06 | 6 | 203 | 3 | 9841925 | ||
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 3.87e-06 | 6 | 203 | 3 | 9971772 | |
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 3.87e-06 | 6 | 203 | 3 | 10074138 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 3.87e-06 | 6 | 203 | 3 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 3.87e-06 | 6 | 203 | 3 | 11709093 | |
| Pubmed | 3.87e-06 | 6 | 203 | 3 | 10049817 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 3.87e-06 | 6 | 203 | 3 | 23875777 | |
| Pubmed | 5.14e-06 | 214 | 203 | 9 | 22199357 | ||
| Pubmed | 6.74e-06 | 7 | 203 | 3 | 22535526 | ||
| Pubmed | 6.74e-06 | 7 | 203 | 3 | 16059920 | ||
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 6.74e-06 | 7 | 203 | 3 | 17504171 | |
| Pubmed | 6.74e-06 | 7 | 203 | 3 | 12242711 | ||
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 6.74e-06 | 7 | 203 | 3 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 6.74e-06 | 7 | 203 | 3 | 22640593 | |
| Pubmed | 6.74e-06 | 7 | 203 | 3 | 22465675 | ||
| Pubmed | 9.47e-06 | 175 | 203 | 8 | 28071719 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ERBB3 ACTB MAP3K20 ACTG1 CDH23 HMCN2 MYO18B ANK3 ZDHHC5 GRM6 ELAVL3 | 1.01e-05 | 361 | 203 | 11 | 26167880 |
| Pubmed | 1.07e-05 | 8 | 203 | 3 | 20147394 | ||
| Pubmed | 1.07e-05 | 8 | 203 | 3 | 23260110 | ||
| Pubmed | 1.07e-05 | 8 | 203 | 3 | 14694110 | ||
| Pubmed | ATAD5 ACTBL2 ACTB ACTG1 TEX10 PPM1J SBF1 KRT5 PSAT1 ANK3 PMPCB PKP4 ZDHHC5 HUWE1 SHOC2 PPM1B PACS1 SBF2 TANC1 | 1.42e-05 | 1049 | 203 | 19 | 27880917 | |
| Pubmed | Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice. | 1.52e-05 | 26 | 203 | 4 | 33905568 | |
| Pubmed | TANC2 TCAF1 ACTB TEX10 SBF1 KCNB1 RPTOR PEX5 ANK3 PKP4 APC HUWE1 NPTN DOCK7 DCHS1 LRP1 ELAVL2 ELAVL3 | 1.59e-05 | 963 | 203 | 18 | 28671696 | |
| Pubmed | 1.60e-05 | 9 | 203 | 3 | 28705793 | ||
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 1.60e-05 | 9 | 203 | 3 | 10556093 | |
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 1.60e-05 | 9 | 203 | 3 | 8892894 | |
| Pubmed | 1.60e-05 | 9 | 203 | 3 | 18775311 | ||
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 2.15e-05 | 256 | 203 | 9 | 24189400 | |
| Pubmed | 2.28e-05 | 10 | 203 | 3 | 1907279 | ||
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 2.28e-05 | 10 | 203 | 3 | 1991513 | |
| Pubmed | 2.28e-05 | 10 | 203 | 3 | 23575248 | ||
| Pubmed | 2.39e-05 | 29 | 203 | 4 | 22613833 | ||
| Pubmed | SART3 ERCC6 MAN2A1 KIF1A ATAD5 ACTBL2 ACTB INTS1 MAP3K20 TEX10 MFF CSDE1 KMT2C SBF1 XRN1 SLC25A11 IQGAP3 PKP4 APC SLC25A1 IGHMBP2 CSTF1 TANC1 | 2.41e-05 | 1497 | 203 | 23 | 31527615 | |
| Pubmed | 2.74e-05 | 30 | 203 | 4 | 34745083 | ||
| Pubmed | Charcot-Marie-Tooth Neuropathy Type 4 – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 3.12e-05 | 11 | 203 | 3 | 20301641 | |
| Pubmed | 3.12e-05 | 11 | 203 | 3 | 30962377 | ||
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 3.12e-05 | 11 | 203 | 3 | 23294842 | |
| Pubmed | 3.12e-05 | 11 | 203 | 3 | 24639464 | ||
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 3.12e-05 | 11 | 203 | 3 | 19639585 | |
| Pubmed | 3.13e-05 | 31 | 203 | 4 | 22282597 | ||
| Pubmed | Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. | 3.18e-05 | 62 | 203 | 5 | 17975119 | |
| Pubmed | SART3 KIF1A INTS1 TEX10 CSDE1 FASN SBF1 XRN1 FN1 POLE NUP88 HUWE1 GSTP1 DOCK7 | 3.34e-05 | 653 | 203 | 14 | 22586326 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 3.36e-05 | 271 | 203 | 9 | 32433965 | |
| Pubmed | Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. | 3.39e-05 | 2 | 203 | 2 | 21778137 | |
| Pubmed | De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. | 3.39e-05 | 2 | 203 | 2 | 22366783 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 3.39e-05 | 2 | 203 | 2 | 15963947 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 7963647 | ||
| Pubmed | Immunohistochemical analysis of transforming growth factor beta-1 in AA and AL renal amyloidosis. | 3.39e-05 | 2 | 203 | 2 | 17285762 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 22077694 | ||
| Pubmed | Recurrent fusion of the genes FN1 and ALK in gastrointestinal leiomyomas. | 3.39e-05 | 2 | 203 | 2 | 27469327 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 31974739 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 27840243 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 3221869 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 21239487 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 2747639 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 35742953 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 21502360 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 6686106 | ||
| Pubmed | Sphingosine kinase 2 regulates insulin receptor trafficking in hepatocytes. | 3.39e-05 | 2 | 203 | 2 | 36408724 | |
| Pubmed | Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity. | 3.39e-05 | 2 | 203 | 2 | 19638415 | |
| Pubmed | Botulinum C2 toxin ADP-ribosylates cytoplasmic beta/gamma-actin in arginine 177. | 3.39e-05 | 2 | 203 | 2 | 3335520 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 1577857 | ||
| Pubmed | Kv2 channels do not function as canonical delayed rectifiers in spinal motoneurons. | 3.39e-05 | 2 | 203 | 2 | 39148717 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 27098652 | ||
| Interaction | ACTG2 interactions | 4.50e-07 | 49 | 196 | 7 | int:ACTG2 | |
| Interaction | REG3A interactions | 4.65e-07 | 17 | 196 | 5 | int:REG3A | |
| Interaction | TOP3B interactions | TANC2 ZXDC SDSL EPRS1 SPHK2 INTS1 PER1 ACTG1 CSDE1 KMT2C FASN SBF1 FAM83F KLHL21 RPTOR XRN1 SLC25A11 ABCD1 QARS1 IQGAP3 ABCC10 HSPG2 POLE AOC2 ZDHHC5 HUWE1 IDUA MST1R MEGF8 PCNX4 SBF2 CPEB4 LRP5 TANC1 SLC45A1 | 6.86e-07 | 1470 | 196 | 35 | int:TOP3B |
| Interaction | EDN3 interactions | 1.06e-05 | 108 | 196 | 8 | int:EDN3 | |
| Cytoband | 5q21-q22 | 1.16e-04 | 4 | 203 | 2 | 5q21-q22 | |
| GeneFamily | Cadherin related | 8.02e-06 | 17 | 142 | 4 | 24 | |
| GeneFamily | Actins | 9.32e-06 | 6 | 142 | 3 | 929 | |
| GeneFamily | Keratins, type II | 5.56e-05 | 27 | 142 | 4 | 609 | |
| GeneFamily | Low density lipoprotein receptors | 1.28e-04 | 13 | 142 | 3 | 634 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.94e-04 | 115 | 142 | 6 | 769 | |
| GeneFamily | Dyneins, axonemal | 2.98e-04 | 17 | 142 | 3 | 536 | |
| GeneFamily | SEC14 family|PRELI domain containing | 9.00e-04 | 6 | 142 | 2 | 1063 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 9.61e-04 | 25 | 142 | 3 | 504 | |
| GeneFamily | Serpin peptidase inhibitors | 3.03e-03 | 37 | 142 | 3 | 739 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.79e-03 | 40 | 142 | 3 | 321 | |
| GeneFamily | ATP binding cassette subfamily C | 4.51e-03 | 13 | 142 | 2 | 807 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 4.51e-03 | 13 | 142 | 2 | 685 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-07 | 181 | 203 | 9 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.20e-07 | 197 | 203 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 199 | 203 | 9 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.42e-07 | 160 | 203 | 8 | 19105debef96ea0c267d6a1d332303ec668ae47e | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-07 | 160 | 203 | 8 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-07 | 160 | 203 | 8 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.80e-07 | 166 | 203 | 8 | b7f303203068b205f382788815df487a0ea148ed | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-06 | 178 | 203 | 8 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-06 | 178 | 203 | 8 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-06 | 185 | 203 | 8 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-06 | 188 | 203 | 8 | 7e27e49ec1eb02fb74c86ec2ccb84751bc778b21 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-06 | 188 | 203 | 8 | 4b14c3ad80507245564d5be96d33fd9361f67dd0 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.69e-06 | 190 | 203 | 8 | d06800ec9f6065c1cc536ed99e8569732272a94f | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.69e-06 | 190 | 203 | 8 | 485073e831afebdb393c7f4b622504d43d1b778b | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.02e-06 | 193 | 203 | 8 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | ASK440-Epithelial-Secretory|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.02e-06 | 193 | 203 | 8 | 50e98d91697c7af6a3de39e52edde6dd2b67b512 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 3.02e-06 | 193 | 203 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-06 | 199 | 203 | 8 | e9009eee7f77b9c9917f8e0e723001d9e76eb553 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Neuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-06 | 200 | 203 | 8 | 6f3fe94107fa2a2ded4888780b36700cce48adb7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-06 | 200 | 203 | 8 | 9b5753726c17dda98d7384a60f26a5eaf4f6c4d6 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-06 | 200 | 203 | 8 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.93e-06 | 200 | 203 | 8 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.90e-06 | 146 | 203 | 7 | 447c05414eda71681a0c07baba900f88ed6165ed | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.39e-06 | 152 | 203 | 7 | ca23261d8ef263cc697b8d7e7cb2afec8bc564f2 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.67e-06 | 153 | 203 | 7 | edf5d026e8e4c685b7c369d70894741bb2cd568e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.67e-06 | 153 | 203 | 7 | 3240d4d690335ba22317b1f3d33f9ea069e93838 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-06 | 154 | 203 | 7 | bd283c2367afb99294e7576a0c0167eb7c69ad6b | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 8.58e-06 | 159 | 203 | 7 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.69e-06 | 162 | 203 | 7 | e0417f1242edf71934fe62bccc55c4678f7ff4ac | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.69e-06 | 162 | 203 | 7 | 8e0f03fcc25b2ea777e8478fbf771699cf93719c | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.69e-06 | 107 | 203 | 6 | d4807f008619dfd3e215d602df0d02b135b1ac37 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.69e-06 | 107 | 203 | 6 | 5907b9632c88d48f293c3c6d37b7ef831fbcdd86 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.69e-06 | 107 | 203 | 6 | 3f24de1afbfd070f9db11c9acd02b90e5eb2511d | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.05e-05 | 164 | 203 | 7 | 583dda853cee9491dbdcb228c23d8deadc20eb08 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 168 | 203 | 7 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 168 | 203 | 7 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 169 | 203 | 7 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 169 | 203 | 7 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | droplet-Lung-21m-Hematologic-Lymphocytic_NK_ILC|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-05 | 171 | 203 | 7 | dfaa6eb9c1835fdcaececc975b303ea8c2e9629d | |
| ToppCell | droplet-Lung-21m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-05 | 171 | 203 | 7 | 91f18271e280e64c7a790ca29e453c10510f525a | |
| ToppCell | droplet-Lung-21m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-05 | 171 | 203 | 7 | 47e5091a2df3f14353aca19c57c8ca518612c981 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 173 | 203 | 7 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 173 | 203 | 7 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 173 | 203 | 7 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-05 | 174 | 203 | 7 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.54e-05 | 174 | 203 | 7 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 175 | 203 | 7 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-05 | 178 | 203 | 7 | c661246269ce26c4fc62e12f86c5f90a2dcfdce0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-05 | 178 | 203 | 7 | e5e5f5b4a27e120a1076b1cb250fa25d0c336956 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 179 | 203 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.85e-05 | 179 | 203 | 7 | 42f3c040f504a91cc69292d39d22b5715c12526f | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.85e-05 | 179 | 203 | 7 | 063c05753ef1b4a18bc1ebbcae62c8cd25d11070 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 180 | 203 | 7 | 0059e5acade6c895fd629767bea1c15f40b0d1b0 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.92e-05 | 180 | 203 | 7 | 7085a851807e6a833965e1366946db0bbc5174e2 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 180 | 203 | 7 | dfb8412e1e06fa7349e66eea2ef27d9ea98b7893 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-05 | 183 | 203 | 7 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-05 | 184 | 203 | 7 | c7073d1b2c4fdb154d87678b92a0629c02116972 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-05 | 184 | 203 | 7 | 1ed558a88215b248431c524ea16f13d9022ae98c | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.21e-05 | 184 | 203 | 7 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-05 | 184 | 203 | 7 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-05 | 188 | 203 | 7 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-05 | 188 | 203 | 7 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.53e-05 | 188 | 203 | 7 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-05 | 188 | 203 | 7 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-05 | 188 | 203 | 7 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.53e-05 | 188 | 203 | 7 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-05 | 188 | 203 | 7 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-05 | 189 | 203 | 7 | f7d57723b8fb0f1e1485f51e3eff93ec0f39761e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.62e-05 | 189 | 203 | 7 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 190 | 203 | 7 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.71e-05 | 190 | 203 | 7 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.80e-05 | 191 | 203 | 7 | 210589095a3f5d5117174caf6ec110b502f27030 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.80e-05 | 191 | 203 | 7 | f98fc372e579ce69409afbbe0f83c03c7ea62632 | |
| ToppCell | Control-Myeloid-MoAM3,_VCAN|Control / Condition, Lineage and Cell class | 2.80e-05 | 191 | 203 | 7 | 76c2fbc62855a65600cd6b8dd1e2d2c3d7415921 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.80e-05 | 191 | 203 | 7 | 2b427741a58921e161101a282d1fe526cd9e760d | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.90e-05 | 192 | 203 | 7 | 4a46f7980ec145be5b4bf8b98265e3e0f2ea4c63 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.90e-05 | 192 | 203 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | facs-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 192 | 203 | 7 | cca2d0fedfbd946c54d6f4fc45887117c8dae58a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 193 | 203 | 7 | 1f978e102a029a6beb10913052cd0a20c7253e8e | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.00e-05 | 193 | 203 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.10e-05 | 194 | 203 | 7 | 66dd0469db797c61b094f47426b5212fe52156e9 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 194 | 203 | 7 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | 15-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 3.10e-05 | 194 | 203 | 7 | 5c1218d239c88082496924653ed2a092dc44a906 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.10e-05 | 194 | 203 | 7 | aaecde88bd54134a938e76cdf059c1c2653e4e77 | |
| ToppCell | facs-Skin-Telogen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 194 | 203 | 7 | ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.10e-05 | 194 | 203 | 7 | d2bafd31bb8333f66b6c714944bceb2f1aa11740 | |
| ToppCell | facs-Skin-Telogen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 194 | 203 | 7 | bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.10e-05 | 194 | 203 | 7 | 840220fe357e6e79fb60a530798be2dc12ce8f32 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT2-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.10e-05 | 194 | 203 | 7 | 5bfc26668fa8f109f2ebc0d5fd98ab5bd219e62c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-05 | 195 | 203 | 7 | bd7526dd80a60ff7bc866e4f5a0e8acdbc10d191 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-05 | 195 | 203 | 7 | 8a04f0e92d10a368ccda5f566ae67ef51f1d34a9 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.20e-05 | 195 | 203 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.20e-05 | 195 | 203 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.20e-05 | 195 | 203 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-05 | 195 | 203 | 7 | 8a9d05f7a5397836b7dfb8ae4f7c4896042ac0fe | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.20e-05 | 195 | 203 | 7 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 3.31e-05 | 196 | 203 | 7 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | Fibroblast|World / shred by cell class for bronchial biopsy | 3.42e-05 | 197 | 203 | 7 | 8bf9846228b6b6721b10375fe54a2fb389ff64a6 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.42e-05 | 197 | 203 | 7 | 5a63c2b824c7d0dbbc706e408459c9b9fe65daaa | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 198 | 203 | 7 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | SBF1 PEX5 HSPG2 COL8A1 PGGHG APC APBA3 IDUA IKZF5 KLHL22 MST1R VWA5A | 1.96e-07 | 196 | 202 | 12 | 3390_DN |
| Drug | Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; MCF7; HT_HG-U133A | SARM1 INTS1 SLC22A7 SPTBN5 ALK HUWE1 IKBKE DNAH17 RBFOX1 ELAVL2 ELAVL3 | 1.75e-06 | 199 | 202 | 11 | 4749_UP |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; PC3; HT_HG-U133A | ATAD5 SERPINB9 SBF1 PGAP1 ALK PLXNB1 HSPG2 AOC2 APC MEGF8 VWA5A | 1.75e-06 | 199 | 202 | 11 | 6675_DN |
| Drug | Nifurtimox [23256-30-6]; Up 200; 14uM; MCF7; HT_HG-U133A | ATAD5 GAS6 PER1 GATM HOXB2 TECPR2 FN1 IDUA GRM6 KLHL22 RBFOX1 | 1.84e-06 | 200 | 202 | 11 | 4953_UP |
| Drug | orthovanadate | ERBB3 ATP7B PDE8A KIF1A ACTBL2 INSR ACTB ACTG1 SBF1 SYK QARS1 GPLD1 AOC2 ABCC5 DNAH17 | 8.57e-06 | 435 | 202 | 15 | CID000061672 |
| Drug | AC1L1HS4 | 8.67e-06 | 32 | 202 | 5 | CID000004267 | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; PC3; HT_HG-U133A | 1.01e-05 | 195 | 202 | 10 | 1214_UP | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A | INTS1 TECPR2 STK24 HSPG2 FN1 POM121L2 SLC48A1 PACS1 CD7 VWA5A | 1.01e-05 | 195 | 202 | 10 | 2805_UP |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; HL60; HT_HG-U133A | 1.01e-05 | 195 | 202 | 10 | 2394_UP | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; PC3; HT_HG-U133A | TANC2 PER1 HOXB2 SERPINB9 ALK NPR2 AOC2 HUWE1 SLC48A1 ELAVL3 | 1.06e-05 | 196 | 202 | 10 | 3726_DN |
| Drug | Kanamycin A sulfate [25389-94-0]; Up 200; 6.8uM; PC3; HT_HG-U133A | 1.10e-05 | 197 | 202 | 10 | 4625_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A | 1.10e-05 | 197 | 202 | 10 | 4433_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.10e-05 | 197 | 202 | 10 | 3708_DN | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; HL60; HT_HG-U133A | 1.15e-05 | 198 | 202 | 10 | 2155_UP | |
| Drug | Antimycin A [1397-94-0]; Up 200; 7.2uM; PC3; HT_HG-U133A | 1.15e-05 | 198 | 202 | 10 | 5053_UP | |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | MAP3K20 FASN SBF1 ABCD1 APC FBXL15 IDUA SLC48A1 KLHL22 VWA5A | 1.21e-05 | 199 | 202 | 10 | 4294_DN |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.21e-05 | 199 | 202 | 10 | 3430_DN | |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A | MAP3K20 PER1 TECPR2 PTBP3 NPR2 FBXL15 SLC48A1 PACS1 ARSB LRP1 | 1.26e-05 | 200 | 202 | 10 | 3713_DN |
| Drug | NVP & EFV | 1.28e-05 | 121 | 202 | 8 | CID000492400 | |
| Drug | Nsc687160 | 1.67e-05 | 18 | 202 | 4 | CID005459290 | |
| Drug | butyrate | ERBB3 KRT74 ACTBL2 ACTB ACTG1 ACTG2 CHAT ITGAX KRT73 FASN KRT71 TONSL KCNN4 KRT5 FN1 POLE APC TGFB1 GSTP1 IGHMBP2 | 1.75e-05 | 767 | 202 | 20 | CID000000264 |
| Drug | BAY 41-2272 | 1.81e-05 | 37 | 202 | 5 | CID009798973 | |
| Drug | D3273 | 2.08e-05 | 94 | 202 | 7 | CID005464587 | |
| Drug | tolytoxin | 2.10e-05 | 19 | 202 | 4 | CID006440827 | |
| Drug | Parthenolide [20554-84-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | 2.52e-05 | 173 | 202 | 9 | 5105_UP | |
| Drug | Soybean Oil | 2.61e-05 | 20 | 202 | 4 | ctd:D013024 | |
| Drug | peroxynitrite | EPRS1 NLRP12 ACTBL2 ACTB ACTG1 ACTG2 CHAT TONSL NPR2 FN1 DUOX2 TGFB1 GUCY1B1 | 3.10e-05 | 373 | 202 | 13 | CID000104806 |
| Drug | NSC312786 | 3.20e-05 | 21 | 202 | 4 | CID000329495 | |
| Drug | AC1L8NVR | 3.20e-05 | 21 | 202 | 4 | CID000384633 | |
| Drug | AC1L1G9T | ERBB3 ACTBL2 INSR ACTB GAS6 ACTG1 ACTG2 KCNB1 TONSL SYK GPLD1 NPR2 FN1 TGFB1 | 3.49e-05 | 433 | 202 | 14 | CID000003591 |
| Drug | 0-to | 3.86e-05 | 141 | 202 | 8 | CID000002051 | |
| Drug | Emetine dihydrochloride [316-42-7]; Down 200; 7.2uM; PC3; HT_HG-U133A | 3.92e-05 | 183 | 202 | 9 | 4243_DN | |
| Drug | H2O2 | EPRS1 ERBB3 ACTBL2 INSR ACTB GAS6 ACTG1 ACTG2 KCNB1 TONSL SYK PEX5 ABCD1 QARS1 GPLD1 FN1 PMPCB POLE AOC2 APC DUOX2 SHOC2 TGFB1 GSTP1 RBFOX1 | 5.21e-05 | 1183 | 202 | 25 | CID000000784 |
| Drug | arabinosyladenine | EPRS1 ATP7B PDE8A ACTBL2 ACTB ACTG1 ACTG2 KCNB1 TONSL QARS1 GPLD1 NPR2 FN1 APC GRM6 NMNAT3 P2RX3 GUCY1B1 P2RY11 | 5.22e-05 | 762 | 202 | 19 | CID000000191 |
| Drug | 17-DMAG; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.47e-05 | 191 | 202 | 9 | 4437_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.93e-05 | 193 | 202 | 9 | 4443_DN | |
| Drug | 0175029-0000 [211245-78-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.93e-05 | 193 | 202 | 9 | 4713_UP | |
| Drug | adenosine 3',5'-cyclic phosphate | PDE8A KRT74 INSR ACTB PER1 ACTG1 ACTG2 CHAT ADCYAP1R1 KRT73 FASN MS4A2 KRT71 TONSL KRT5 NPR2 FN1 GRM6 TGFB1 GUCY1B1 P2RY11 | 6.06e-05 | 907 | 202 | 21 | CID000000274 |
| Drug | Rp-cAMPS | 6.17e-05 | 194 | 202 | 9 | CID006426631 | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Up 200; 14.2uM; PC3; HT_HG-U133A | 6.17e-05 | 194 | 202 | 9 | 4660_UP | |
| Drug | Sulfanilamide [63-74-1]; Up 200; 23.2uM; PC3; HT_HG-U133A | 6.17e-05 | 194 | 202 | 9 | 4474_UP | |
| Drug | DL-arginine | NLRP12 ACTBL2 ACTB GATM ACTG1 ACTG2 CHAT QARS1 IL4I1 NPR2 TGFB1 GUCY1B1 | 6.22e-05 | 344 | 202 | 12 | CID000000232 |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 6.42e-05 | 195 | 202 | 9 | 5325_UP | |
| Drug | Gemfibrozil [25812-30-0]; Up 200; 16uM; PC3; HT_HG-U133A | 6.42e-05 | 195 | 202 | 9 | 2113_UP | |
| Drug | Antipyrine [60-80-0]; Down 200; 21.2uM; PC3; HT_HG-U133A | KIF1A MAP3K20 KCNN4 PLXNB1 COL7A1 COL8A1 FBXL15 PACS1 GUCY1B1 | 6.42e-05 | 195 | 202 | 9 | 4251_DN |
| Drug | Beta-sistosterol [83-46-5]; Down 200; 9.6uM; PC3; HT_HG-U133A | 6.42e-05 | 195 | 202 | 9 | 4073_DN | |
| Drug | AC1Q6LQU | 6.57e-05 | 48 | 202 | 5 | CID000072380 | |
| Drug | Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | 6.67e-05 | 196 | 202 | 9 | 4482_UP | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A | 6.67e-05 | 196 | 202 | 9 | 5577_UP | |
| Drug | Alcuronium chloride [15180-03-7]; Up 200; 5.4uM; MCF7; HT_HG-U133A | SARM1 SLC22A7 SERPINB8 KCNB1 GPLD1 SLC48A1 VWA5A DNAH17 DCHS1 | 6.67e-05 | 196 | 202 | 9 | 4409_UP |
| Drug | Orlistat; Up 200; 10uM; MCF7; HT_HG-U133A | 6.67e-05 | 196 | 202 | 9 | 6905_UP | |
| Drug | 0175029-0000 [211245-78-2]; Down 200; 1uM; PC3; HT_HG-U133A | 6.94e-05 | 197 | 202 | 9 | 3694_DN | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A | 6.94e-05 | 197 | 202 | 9 | 4295_DN | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 6.94e-05 | 197 | 202 | 9 | 3939_UP | |
| Drug | Glimepiride [93479-97-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 6.94e-05 | 197 | 202 | 9 | 2809_UP | |
| Drug | Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 6.94e-05 | 197 | 202 | 9 | 2796_DN | |
| Drug | Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 6.94e-05 | 197 | 202 | 9 | 5353_UP | |
| Drug | Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; PC3; HT_HG-U133A | 6.94e-05 | 197 | 202 | 9 | 5099_UP | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; PC3; HT_HG-U133A | 7.22e-05 | 198 | 202 | 9 | 6641_DN | |
| Drug | Trioxsalen [3902-71-4]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 7.22e-05 | 198 | 202 | 9 | 6216_UP | |
| Drug | Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; PC3; HT_HG-U133A | 7.22e-05 | 198 | 202 | 9 | 6354_UP | |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A | 7.22e-05 | 198 | 202 | 9 | 6742_DN | |
| Drug | Methantheline bromide [53-46-3]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 7.22e-05 | 198 | 202 | 9 | 6254_UP | |
| Drug | methyl ethyl ketone | EPRS1 NLRP12 SPHK2 ERBB3 INSR ACTB ACTG1 ACTG2 TONSL SYK STK24 GPLD1 FN1 ITLN1 SHOC2 TGFB1 | 7.47e-05 | 587 | 202 | 16 | CID000006569 |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 7.50e-05 | 199 | 202 | 9 | 1488_DN | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; PC3; HT_HG-U133A | 7.79e-05 | 200 | 202 | 9 | 6628_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 7.79e-05 | 200 | 202 | 9 | 3765_DN | |
| Drug | Calycanthine [595-05-1]; Up 200; 11.6uM; PC3; HT_HG-U133A | 7.79e-05 | 200 | 202 | 9 | 5744_UP | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Down 200; 8uM; PC3; HT_HG-U133A | 7.79e-05 | 200 | 202 | 9 | 5772_DN | |
| Drug | Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; HL60; HT_HG-U133A | 7.79e-05 | 200 | 202 | 9 | 3062_DN | |
| Drug | 9-ethyl-6,6-dimethyl-8-(4-oxetan-3-ylpiperazin-1-yl)-11-oxo-6,11-dihydro-5H-benzo(b)carbazole-3-carbonitrile | 7.83e-05 | 2 | 202 | 2 | ctd:C562235 | |
| Drug | cymarose | 7.89e-05 | 10 | 202 | 3 | CID000441417 | |
| Drug | alitretinoin | INSR PER1 ACTG2 ITGAX FASN SERPINB8 SERPINB9 KRT5 FN1 TGFB1 MTTP | 8.35e-05 | 301 | 202 | 11 | ctd:C103303 |
| Drug | AC1L2DAI | ACTBL2 ACTB ACTG1 ACTG2 HSPG2 KRT5 NPBWR1 FN1 ABCC5 IGHMBP2 MTTP | 9.12e-05 | 304 | 202 | 11 | CID000004984 |
| Drug | EGFR inhibitor | 9.95e-05 | 120 | 202 | 7 | CID009549299 | |
| Drug | AC1L1G2K | 1.04e-04 | 84 | 202 | 6 | CID000003498 | |
| Drug | 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone | 1.04e-04 | 28 | 202 | 4 | ctd:C024709 | |
| Drug | bistheonellide A | 1.08e-04 | 11 | 202 | 3 | CID006441172 | |
| Drug | Viroisin | 1.08e-04 | 11 | 202 | 3 | CID000119538 | |
| Drug | wartmannin | ERBB3 ACTBL2 INSR ACTB GAS6 ACTG1 ACTG2 FASN MS4A2 TONSL SYK MYO18B GPLD1 FN1 ITLN1 TGFB1 MST1R SLC25A1 SBF2 | 1.18e-04 | 811 | 202 | 19 | CID000005691 |
| Drug | Hypertensin II | ACTBL2 ACTB ACTG1 LRP1B TONSL KCNN4 GPLD1 NPR2 FN1 DUOX2 TGFB1 CD7 LRP1 | 1.27e-04 | 429 | 202 | 13 | CID000025476 |
| Drug | superoxide | EPRS1 NLRP12 ATP7B CHAT ITGAX TONSL SYK GPLD1 NPR2 FN1 DUOX2 SHOC2 GUCY1B1 P2RY11 | 1.30e-04 | 490 | 202 | 14 | CID000520535 |
| Drug | azaspiracid | 1.38e-04 | 30 | 202 | 4 | CID006451158 | |
| Drug | BFDGE | 1.43e-04 | 12 | 202 | 3 | CID000091511 | |
| Drug | losartan | ACTBL2 ACTB ACTG1 ACTG2 ITGAX HSPG2 KRT5 COL7A1 COL8A1 FN1 DUOX2 TGFB1 | 1.51e-04 | 378 | 202 | 12 | CID000003961 |
| Drug | AC1L1BDQ | 1.62e-04 | 173 | 202 | 8 | CID000001394 | |
| Drug | dihydrocytochalasin B | 1.64e-04 | 58 | 202 | 5 | CID000003064 | |
| Drug | C18:1n-7 | 1.71e-04 | 92 | 202 | 6 | CID000122325 | |
| Drug | AC1L1IZE | 1.72e-04 | 131 | 202 | 7 | CID000004799 | |
| Drug | carboplatin | 1.72e-04 | 131 | 202 | 7 | CID000038904 | |
| Drug | phenylarsine oxide | 1.83e-04 | 275 | 202 | 10 | CID000004778 | |
| Drug | sodium pentaborate | 2.01e-04 | 33 | 202 | 4 | ctd:C538809 | |
| Drug | oleoyl-lysophosphatidic acid | SPHK2 ERBB3 ACTBL2 ACTB ACTG1 TONSL KCNN4 GPLD1 NPR2 FN1 AOC2 TGFB1 | 2.06e-04 | 391 | 202 | 12 | CID000003987 |
| Drug | AC1L1B55 | ERBB3 ACTBL2 ACTB ACTG1 ITGAX FASN TONSL COL7A1 FN1 TGFB1 GSTP1 CD7 ELAVL3 | 2.22e-04 | 454 | 202 | 13 | CID000001287 |
| Drug | Calcein AM | 2.25e-04 | 62 | 202 | 5 | CID000390986 | |
| Drug | glycerophosphoinositol | 2.25e-04 | 62 | 202 | 5 | CID000167572 | |
| Drug | N,N'-p-phenylenedimaleimide | 2.26e-04 | 34 | 202 | 4 | CID000076765 | |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 2.26e-04 | 34 | 202 | 4 | CID000001312 | |
| Drug | AC1N9J6O | 2.29e-04 | 182 | 202 | 8 | CID004411483 | |
| Drug | kabiramide C | 2.33e-04 | 14 | 202 | 3 | CID005288658 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 7.50e-10 | 8 | 200 | 5 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 7.50e-10 | 8 | 200 | 5 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 7.50e-10 | 8 | 200 | 5 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 7.50e-10 | 8 | 200 | 5 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 3.34e-09 | 10 | 200 | 5 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 3.34e-09 | 10 | 200 | 5 | DOID:13832 (implicated_via_orthology) | |
| Disease | Carcinomatosis | 1.83e-06 | 163 | 200 | 9 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.83e-06 | 163 | 200 | 9 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.83e-06 | 163 | 200 | 9 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.83e-06 | 163 | 200 | 9 | C0205696 | |
| Disease | Carcinoma | 1.93e-06 | 164 | 200 | 9 | C0007097 | |
| Disease | glutathione s-transferase p measurement | 1.05e-05 | 7 | 200 | 3 | EFO_0020410 | |
| Disease | tumor necrosis factor receptor superfamily member 16 measurement | 2.50e-05 | 9 | 200 | 3 | EFO_0802168 | |
| Disease | atopic dermatitis (is_implicated_in) | 2.72e-05 | 26 | 200 | 4 | DOID:3310 (is_implicated_in) | |
| Disease | Van Maldergem Wetzburger Verloes syndrome | 4.57e-05 | 2 | 200 | 2 | C1832390 | |
| Disease | Van Maldergem syndrome | 4.57e-05 | 2 | 200 | 2 | cv:C1832390 | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 4.57e-05 | 2 | 200 | 2 | C1855722 | |
| Disease | Periventricular gray matter heterotopia | 4.57e-05 | 2 | 200 | 2 | C1849173 | |
| Disease | Baraitser-Winter syndrome | 4.57e-05 | 2 | 200 | 2 | cv:C1853623 | |
| Disease | Fryns-Aftimos Syndrome | 4.57e-05 | 2 | 200 | 2 | C1853623 | |
| Disease | Mammary Carcinoma, Animal | 5.43e-05 | 142 | 200 | 7 | C1257925 | |
| Disease | Animal Mammary Neoplasms | 5.43e-05 | 142 | 200 | 7 | C0024667 | |
| Disease | persulfide dioxygenase ETHE1, mitochondrial measurement | 6.45e-05 | 12 | 200 | 3 | EFO_0008258 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 8.34e-05 | 13 | 200 | 3 | cv:C4082197 | |
| Disease | transmembrane protein 87B measurement | 8.34e-05 | 13 | 200 | 3 | EFO_0802158 | |
| Disease | Alzheimer disease, age at onset | THSD4 DCHS2 ERBB3 ADCYAP1R1 TMEM132C RPTOR AGBL1 HSPG2 RBFOX1 DCHS1 | 1.26e-04 | 343 | 200 | 10 | EFO_0004847, MONDO_0004975 |
| Disease | alpha-(1,3)-fucosyltransferase 9 measurement | 1.37e-04 | 3 | 200 | 2 | EFO_0801367 | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 1.37e-04 | 3 | 200 | 2 | C1842563 | |
| Disease | NHP2-like protein 1 measurement | 1.37e-04 | 3 | 200 | 2 | EFO_0801840 | |
| Disease | histone deacetylase complex subunit SAP18 measurement | 1.37e-04 | 3 | 200 | 2 | EFO_0801680 | |
| Disease | Mesothelioma | 1.70e-04 | 41 | 200 | 4 | C0025500 | |
| Disease | Charcot-Marie-Tooth disease | 1.87e-04 | 42 | 200 | 4 | cv:C0007959 | |
| Disease | Carcinoma in situ of stomach | 1.94e-04 | 17 | 200 | 3 | C0154060 | |
| Disease | Benign neoplasm of stomach | 1.94e-04 | 17 | 200 | 3 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.94e-04 | 17 | 200 | 3 | C0496905 | |
| Disease | RS-warfarin measurement | 2.46e-04 | 128 | 200 | 6 | EFO_0803325 | |
| Disease | Paraparesis, Spastic | 2.72e-04 | 4 | 200 | 2 | C0037771 | |
| Disease | pro-FMRFamide-related neuropeptide FF measurement | 2.72e-04 | 4 | 200 | 2 | EFO_0801911 | |
| Disease | prostate carcinoma in situ (biomarker_via_orthology) | 2.72e-04 | 4 | 200 | 2 | DOID:8634 (biomarker_via_orthology) | |
| Disease | inosine-5'-monophosphate dehydrogenase 1 measurement | 2.72e-04 | 4 | 200 | 2 | EFO_0008158 | |
| Disease | arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 measurement | 2.72e-04 | 4 | 200 | 2 | EFO_0803306 | |
| Disease | Colorectal Carcinoma | ERCC6 ATP7B PER1 MFF KRT73 KMT2C COL7A1 FN1 POLE APC ABCC5 TGFB1 DCHS1 LRP1 | 3.33e-04 | 702 | 200 | 14 | C0009402 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.42e-04 | 49 | 200 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Stomach Carcinoma | 3.73e-04 | 21 | 200 | 3 | C0699791 | |
| Disease | Neoplastic Cell Transformation | 3.83e-04 | 139 | 200 | 6 | C0007621 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.83e-04 | 139 | 200 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | drebrin-like protein measurement | 4.51e-04 | 5 | 200 | 2 | EFO_0020333 | |
| Disease | Woolly hair, congenital | 4.51e-04 | 5 | 200 | 2 | C0345427 | |
| Disease | serine/threonine-protein kinase 17B measurement | 4.51e-04 | 5 | 200 | 2 | EFO_0008281 | |
| Disease | n-acetyltransferase 14 measurement | 4.51e-04 | 5 | 200 | 2 | EFO_0801819 | |
| Disease | lysozyme-like protein 2 measurement | 4.51e-04 | 5 | 200 | 2 | EFO_0801779 | |
| Disease | low-density lipoprotein receptor-related protein 1, soluble measurement | 4.51e-04 | 5 | 200 | 2 | EFO_0801772 | |
| Disease | general transcription factor II-I measurement | 4.51e-04 | 5 | 200 | 2 | EFO_0801623 | |
| Disease | partial thromboplastin time | 5.59e-04 | 24 | 200 | 3 | EFO_0004310 | |
| Disease | complement component 1 q subcomponent-binding protein, mitochondrial measurement | 6.74e-04 | 6 | 200 | 2 | EFO_0020280 | |
| Disease | CD63 antigen measurement | 6.74e-04 | 6 | 200 | 2 | EFO_0022033 | |
| Disease | Hypotrichosis | 6.74e-04 | 6 | 200 | 2 | C0020678 | |
| Disease | protocadherin-10 measurement | 6.74e-04 | 6 | 200 | 2 | EFO_0801978 | |
| Disease | protein NDRG4 measurement | 6.74e-04 | 6 | 200 | 2 | EFO_0801954 | |
| Disease | nischarin measurement | 6.74e-04 | 6 | 200 | 2 | EFO_0801841 | |
| Disease | NTF2-related export protein 1 measurement | 6.74e-04 | 6 | 200 | 2 | EFO_0801847 | |
| Disease | n-acetylserotonin O-methyltransferase-like protein measurement | 6.74e-04 | 6 | 200 | 2 | EFO_0801818 | |
| Disease | arylsulfatase B measurement | 6.74e-04 | 6 | 200 | 2 | EFO_0008030 | |
| Disease | solute carrier family 35 member G2 measurement | 6.74e-04 | 6 | 200 | 2 | EFO_0802080 | |
| Disease | fructose-1,6-bisphosphatase 1 measurement | 6.74e-04 | 6 | 200 | 2 | EFO_0801606 | |
| Disease | Mammary Neoplasms, Experimental | 6.81e-04 | 155 | 200 | 6 | C0024668 | |
| Disease | Non-Small Cell Lung Carcinoma | 7.04e-04 | 156 | 200 | 6 | C0007131 | |
| Disease | protein S100-A12 measurement | 9.39e-04 | 7 | 200 | 2 | EFO_0010925 | |
| Disease | extracellular sulfatase Sulf-2 measurement | 9.39e-04 | 7 | 200 | 2 | EFO_0801596 | |
| Disease | dipeptidyl peptidase 2 measurement | 9.39e-04 | 7 | 200 | 2 | EFO_0020326 | |
| Disease | arachidonate 15-lipoxygenase B measurement | 9.39e-04 | 7 | 200 | 2 | EFO_0801391 | |
| Disease | remission | 9.39e-04 | 7 | 200 | 2 | EFO_0009785 | |
| Disease | Uveoretinal Coloboma | 9.39e-04 | 7 | 200 | 2 | C4554007 | |
| Disease | alcohol dependence measurement, electroencephalogram measurement | 9.39e-04 | 7 | 200 | 2 | EFO_0004357, EFO_0007835 | |
| Disease | Wooly hair | 9.39e-04 | 7 | 200 | 2 | C0343073 | |
| Disease | rho GTPase-activating protein 30 measurement | 9.39e-04 | 7 | 200 | 2 | EFO_0802012 | |
| Disease | ribonucleoside-diphosphate reductase subunit M2 B measurement | 9.39e-04 | 7 | 200 | 2 | EFO_0802022 | |
| Disease | sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) measurement | 9.39e-04 | 7 | 200 | 2 | EFO_0803304 | |
| Disease | Schizophrenia | DOCK4 ERBB3 ACTB CHAT ADCYAP1R1 KCNB1 ALK PSAT1 ANK3 APC TGFB1 GSTP1 NPTN LRP1 ELAVL2 | 1.07e-03 | 883 | 200 | 15 | C0036341 |
| Disease | Malignant neoplasm of breast | GABRP ERBB3 ERCC6 ATP7B PER1 FASN FAM83F ALK PLXNB1 AMFR KRT5 COL7A1 NPBWR1 FN1 ADAMTS1 GRM6 GSTP1 | 1.09e-03 | 1074 | 200 | 17 | C0006142 |
| Disease | E3 ubiquitin-protein ligase RNF13 measurement | 1.25e-03 | 8 | 200 | 2 | EFO_0801556 | |
| Disease | bone morphogenetic protein 6 measurement | 1.25e-03 | 8 | 200 | 2 | EFO_0020186 | |
| Disease | ovarian cancer (implicated_via_orthology) | 1.25e-03 | 8 | 200 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | chemotherapy-induced alopecia, methylcobalamin deficiency type cblE | 1.25e-03 | 8 | 200 | 2 | EFO_0005400, MONDO_0009354 | |
| Disease | cytidine measurement | 1.25e-03 | 8 | 200 | 2 | EFO_0800645 | |
| Disease | breast cancer anti-estrogen resistance protein 3 measurement | 1.25e-03 | 8 | 200 | 2 | EFO_0008040 | |
| Disease | CD27 antigen measurement | 1.25e-03 | 8 | 200 | 2 | EFO_0008078 | |
| Disease | sialic acid-binding Ig-like lectin 12 measurement | 1.25e-03 | 8 | 200 | 2 | EFO_0802066 | |
| Disease | white matter volume measurement | 1.32e-03 | 32 | 200 | 3 | EFO_0008320 | |
| Disease | disease recurrence, unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 1.44e-03 | 33 | 200 | 3 | EFO_0003761, EFO_0004952, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | Acute Coronary Syndrome | 1.44e-03 | 33 | 200 | 3 | C0948089 | |
| Disease | stomach cancer (is_implicated_in) | 1.47e-03 | 72 | 200 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | apolipoprotein D measurement | 1.59e-03 | 9 | 200 | 2 | EFO_0020156 | |
| Disease | tumor necrosis factor ligand superfamily member 14 measurement | 1.59e-03 | 9 | 200 | 2 | EFO_0010613 | |
| Disease | angiotensin-converting enzyme measurement | 1.59e-03 | 9 | 200 | 2 | EFO_0006515 | |
| Disease | Congenital ocular coloboma (disorder) | 1.59e-03 | 9 | 200 | 2 | C0009363 | |
| Disease | leucine-rich repeat serine/threonine-protein kinase 2 measurement | 1.59e-03 | 9 | 200 | 2 | EFO_0021876 | |
| Disease | Hypertensive disease | 1.94e-03 | 190 | 200 | 6 | C0020538 | |
| Disease | response to corticosteroid, age at assessment | 1.98e-03 | 10 | 200 | 2 | EFO_0008007, GO_0031960 | |
| Disease | Congenital myasthenic syndrome | 1.98e-03 | 10 | 200 | 2 | cv:C0751882 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALYRTGSVGIGNLQR | 441 | Q99569 | |
| SRSLLYVGNRQASII | 1781 | Q96QE3 | |
| TTIGGRSLYNRGFSL | 416 | P21860 | |
| RNATYLVRGSLGANT | 121 | Q01362 | |
| NVAGSTLSRYLRDLL | 46 | Q5JWF8 | |
| SLAGRDLNRNYTSLL | 416 | Q8NEM8 | |
| ITCSTSGGLRGIYLR | 46 | P09564 | |
| SLGYNRLILQIGRGT | 31 | Q9NP73 | |
| AIQAVLSLYASGRTT | 136 | Q562R1 | |
| SRSQLLTGRYQIHTG | 96 | Q5FYB1 | |
| LTRTNGITYASVALA | 586 | P35670 | |
| IQAVLSLYTSGRTTG | 136 | Q9BYX7 | |
| IQAVLSLYASGRTTG | 136 | P60709 | |
| IQAVLSLYASGRTTG | 136 | P63261 | |
| GIFNYATRLGRRSKS | 4741 | Q6V0I7 | |
| FGARYLGSTQLVSER | 221 | O96018 | |
| AIQAVLSLYASGRTT | 136 | P63267 | |
| GRNSNSKRLLGYVAT | 511 | O75534 | |
| AIASLNGYRLGERVL | 341 | Q14576 | |
| TEGRLTKARNSLGLY | 56 | Q6UXH0 | |
| TKARNSLGLYGRTIE | 61 | Q6UXH0 | |
| AGSRLTLSLRGSSYG | 511 | P20594 | |
| LRGTLYNTGRHVSFL | 96 | O75493 | |
| SSSRTYRVGLGRHNL | 76 | P08217 | |
| QQYSRLGLRETAGIG | 1211 | Q9H251 | |
| LAGLSYSKIRTRGSN | 546 | Q03468 | |
| RAVNRGYVTSLLGLH | 181 | Q96MI9 | |
| GYALGAGTRLRSVLS | 11 | C0HLV8 | |
| FRYELGSGLAVLRSA | 3991 | P98160 | |
| GVVLRYSGSSAALER | 796 | Q9UHI8 | |
| RIAGSQLSSRLQYFG | 571 | P20702 | |
| IQRGLSRSVSYSILG | 906 | Q17RG1 | |
| SYTLLRAARSRGAGT | 226 | P33897 | |
| TRYLDSSFGLGRNSR | 376 | O75106 | |
| AGRSLYFGENRLRST | 31 | O75439 | |
| LAGLSVLRATGATYR | 1111 | Q5T3U5 | |
| IQAVLSLYTSGRTTG | 836 | A5A3E0 | |
| RDAGANASILYRLAG | 1991 | Q96JQ0 | |
| LVASGGVASNFYIRR | 321 | Q9H4B0 | |
| TLAAYGALGRAVLRS | 221 | Q96G91 | |
| LLRYRTDTGFLQTLG | 166 | Q8WWA0 | |
| SNVYLARSRIQGLGL | 4771 | Q8NEZ4 | |
| ARSRIQGLGLYAARD | 4776 | Q8NEZ4 | |
| RLNGSFRYVIISQGL | 1981 | Q9NZR2 | |
| YLASRRIRTGSVCGS | 566 | Q4G0Z9 | |
| LQGSRARSYGSLVQS | 16 | Q96S90 | |
| RSLYSLGGARSISFN | 46 | Q86Y46 | |
| AVLLRSGVLLNASYR | 166 | O15554 | |
| SGVLLNASYRSIGAL | 171 | O15554 | |
| SLYTALTEARRNLGL | 551 | Q16706 | |
| GLAGSDLRHLVQSYR | 126 | Q99684 | |
| GILSLIQSSTRRAYQ | 226 | Q9GZY8 | |
| VSRNLLRLLTSTCGY | 346 | Q8N201 | |
| AVHYIGSRLGRTLTG | 16 | P50440 | |
| RDYQRLGLGTISGSS | 1116 | Q86WG5 | |
| LRQSRNYLGGFALSV | 41 | P43405 | |
| ASNVAGSTELRYGLR | 1966 | Q8NDA2 | |
| ALQRRLNGLSSSVEY | 246 | Q8WVP7 | |
| LNGAYRTVLVSSGLR | 3131 | Q07954 | |
| VVGYGRLGQSLVSRL | 11 | A6ND91 | |
| GSRSLYNLGGSKRIS | 61 | P13647 | |
| VTRNTGLILYEGQSR | 441 | Q5SZK8 | |
| AIRRAYLDGSGAQTL | 396 | O75197 | |
| AGYQALRLARALLDG | 421 | Q14164 | |
| VSLLLSGVVAYFRGR | 611 | Q9NRD8 | |
| KGRSGTLATLQYALA | 156 | O15534 | |
| NRITLLYGSTGGTAL | 161 | Q63HM2 | |
| GRYGLIQAAAVATSR | 271 | O43157 | |
| LYSGSGILRRSNLNI | 636 | P55157 | |
| IRSRYNLGISCINLG | 556 | P50542 | |
| DGLRRLSGNEYVLST | 451 | O60658 | |
| TARRGLSLLLVGGYS | 1626 | Q7Z7M0 | |
| SGYDTILRVLGSNVR | 81 | Q02153 | |
| AYTALLSSVLQRGGV | 186 | Q07864 | |
| YSVRIRATSLAGNGS | 921 | P06213 | |
| NRTTLYSGTGLSVNR | 381 | O75167 | |
| RLLATVTNAYLGTRV | 21 | Q32M88 | |
| TSNLGYSRRALINLS | 186 | Q9H5V7 | |
| TSRLSGNRGVQYTRL | 3131 | Q7Z6Z7 | |
| RLEALGLVSARNGYQ | 1446 | Q86VI3 | |
| LQLGLRAAYSGISSV | 6 | Q6P1K1 | |
| AGLLRQATYTTTRLG | 86 | Q02978 | |
| GGNESSIYLRLARST | 341 | P41586 | |
| VAAVGGQSYLSSILR | 626 | Q6VY07 | |
| YQRLGLGTLSSSLSR | 1131 | O95248 | |
| RDSGRNGLIRYSIAS | 1006 | Q6V1P9 | |
| GGARRLRTAYTNTQL | 141 | P14652 | |
| SYGRLVARAVLGGLS | 6 | Q8NI37 | |
| SGGQRQRISLARALY | 686 | O15440 | |
| YRLLGSLRTCIGNNV | 251 | Q6ICH7 | |
| YVRGSGTRLREAASA | 411 | Q969P0 | |
| LLQYIRAVRFNGSAG | 441 | O15303 | |
| AARRLFLGLGTTLSY | 651 | O15303 | |
| GFTLRRSYNELGLLI | 321 | Q14721 | |
| STTACRGRLYAIGSL | 416 | Q9UJP4 | |
| IYVLGGRSHNRGSRT | 546 | Q53GT1 | |
| YIVQSRRLFSLATGG | 711 | Q8N1I0 | |
| VRRSRGQLGTYTIAS | 1411 | Q96N67 | |
| ASGRLLSYRGERVAA | 256 | Q8N9W5 | |
| ISLIRGGRSEYGAAL | 441 | P13671 | |
| GKQSLSRLAAYISGL | 2806 | Q9UFH2 | |
| QLGATGAYRARALEL | 236 | Q01850 | |
| RAQITGYRLTVGLTR | 1021 | P02751 | |
| ELQLRYNGVGRVTSS | 356 | Q14393 | |
| SNTILRHLGRTLGLY | 66 | P09211 | |
| LQRTLIYSISLGGDT | 301 | Q9NX46 | |
| SSLGGAYKQLVRARF | 566 | O15033 | |
| GNTALGIARRLGYIS | 796 | Q12955 | |
| GRLLALRTLLSQGYN | 81 | Q8WWX0 | |
| TISLSSIRLIQAGAY | 16 | P27658 | |
| LAAVLQDYGRSRGIA | 3336 | Q0VDD8 | |
| SLNGYRLGDRVLQVS | 336 | Q12926 | |
| LVTTRGSTGRGLSYN | 96 | P35475 | |
| RSRNKYGRGSISLNS | 676 | Q9NYL2 | |
| SQLLTGRYQIRTGLQ | 96 | P15848 | |
| VRLNVGGTYFLTTRQ | 46 | Q9NXV2 | |
| QAGLSYTVRVSARVG | 566 | Q02388 | |
| GSDSSLLINARTYGR | 411 | Q17RY0 | |
| FRLRGYSTGKTTAIL | 216 | Q6DWJ6 | |
| STGRTLVRYTGAGLS | 336 | Q05048 | |
| KLVLTSRSGIRTGYQ | 1911 | P49327 | |
| SVRYAGRRLTQAGTL | 396 | Q9Y694 | |
| QTYGARGKGRTQLSL | 901 | Q15020 | |
| LQYEHTRSVGRGSSL | 276 | Q9UDX3 | |
| LQYEHTRSVGRGSSL | 276 | B5MCN3 | |
| GTGLATLSRNLYVVL | 651 | Q9Y2W3 | |
| QRITGLRALAGLVYN | 301 | Q9UHL4 | |
| GLRAGLKRTYSGVSQ | 4156 | Q8TE73 | |
| GNRLIRLFSNGTVLY | 136 | O00591 | |
| GSLRASESNRVTGVY | 1311 | Q12756 | |
| GILTGRCVNYSSVLR | 131 | P56373 | |
| GLAGNSAVLYVLLRA | 51 | P48145 | |
| SCLSDRLQYSRIVGG | 251 | Q96RQ9 | |
| GGSRRLRTAYTNTQL | 141 | O43364 | |
| SLVLNKGRAYTASLG | 221 | Q99567 | |
| LRAVYVRSESSQGGA | 61 | Q6ZN16 | |
| YNRISAGCLSRLGLE | 181 | Q9BQI9 | |
| RGLSYRGLARTTLSG | 221 | P00748 | |
| GQAYVALSRARSLQG | 576 | Q9H611 | |
| ATGILLYGLASRLRD | 51 | P47897 | |
| GLVLSSLQASIYRGG | 376 | Q9NWB1 | |
| LSLRTYLVGNSLSLA | 106 | P07814 | |
| RLTRTRGYQAAGAEL | 91 | Q7Z5M5 | |
| LEAVRLYLGTRGNLT | 141 | Q96HE8 | |
| LQRIGTVGLYRAQDS | 266 | Q8N3T6 | |
| QVLIAASSYGRGRLV | 46 | Q9Y4C2 | |
| GQVLIAASSYGRGRL | 46 | A6NFQ2 | |
| LVQRLQRYSLSGGGT | 426 | Q9Y6E0 | |
| YLAQRRGAGLRSLSL | 186 | Q9H469 | |
| RSVGGIRASLYNAVT | 336 | Q9Y617 | |
| SRYTALAQALVLGAR | 456 | Q5JR12 | |
| GNLSSLSRLGLRYNR | 281 | Q9UQ13 | |
| SRLLILGGANVNYRT | 916 | Q9C0D5 | |
| SRLLILGGANINYRT | 866 | Q9HCD6 | |
| SLTQRGVIYNLLGLA | 831 | Q8TF17 | |
| EQGRRLLLSYSTATL | 116 | Q9BR26 | |
| GSYKQVRSIGSIALR | 96 | Q75T13 | |
| GQLDLLRSNTGLLYR | 61 | Q9H1D9 | |
| RVNGSLAVSRALGDY | 191 | O75688 | |
| LAGRVGLHYSSTVAR | 306 | Q8NEG4 | |
| ASIYRGGTLSSKRNA | 241 | Q96KW2 | |
| SSYGNIRAVATARSL | 721 | Q8N122 | |
| AAIYSGLLRRLQAEG | 281 | Q96GA7 | |
| GTQYLLRTANRLFGE | 81 | P50452 | |
| GRGARLQTALLVLQY | 736 | Q9NRC6 | |
| RVALEYISSGNRSLS | 401 | Q9UM73 | |
| SGLALLGTIISAYRA | 21 | Q9UKV5 | |
| GALAFLVGTLTYRSQ | 611 | P25054 | |
| ATALGLERRSVYTGQ | 31 | Q8IUL8 | |
| QLRFAASLISGVLSY | 231 | P28329 | |
| AVYLNSGSSLLGGLR | 871 | O60296 | |
| LYGRALRVLQAQGSS | 31 | Q15785 | |
| SGGSARTDYRAIQLA | 711 | Q2QGD7 | |
| QGLGLSVDSARRYSL | 296 | Q8N8G2 | |
| GTQYLLRTANRLFGE | 81 | P50453 | |
| GTVLGLATLHTYRGR | 361 | Q9NRA0 | |
| ISYRRNSGSQLASLL | 566 | Q6SZW1 | |
| GTVLTVLNAARRYLG | 221 | Q96N76 | |
| RGLDLRVSGYLNLAA | 311 | Q92504 | |
| QVSSQRTGLYGRLLV | 51 | P38935 | |
| STSRAAYQAAIRGVG | 786 | Q96HA7 | |
| AVLALYNSTRDRVAG | 76 | P01137 | |
| VYGRNAAALSQALRL | 46 | Q8IZQ5 | |
| TAYGSNGVSVLRITR | 91 | Q9Y639 | |
| RSSLGARLSGALHVY | 821 | P80108 | |
| VLASRLGVSGYLVSR | 916 | Q8IZH2 | |
| RSHGVLGLYRGLSSL | 76 | P53007 | |
| VSSQFRLRYLVGGLS | 291 | Q9NXF1 | |
| GSFLIRLSDRATGYI | 71 | A6NKC9 | |
| DLSGIASGGRLYISR | 306 | O75635 | |
| IFRGQRLISYAQLTG | 491 | O00534 | |
| IIRTSGDLYLQTGLS | 906 | O15040 | |
| AGVALRRELGSLNSY | 201 | Q6ZMU5 | |
| SGQRLYGKVLRATLS | 416 | O95758 | |
| YQTTGASTLRRGRAG | 2281 | Q8IUG5 | |
| GIIYAGSRALSRLAI | 81 | Q24JQ0 | |
| EVILNYGRLRGTLSA | 71 | Q9NRH1 | |
| SRYTGLRTHLGLATN | 321 | Q9C0B5 | |
| AIYDLLSITLGRRGQ | 381 | Q9ULT0 | |
| YLLRFLGQNLSVRTG | 116 | O43692 | |
| LGQNLSVRTGRYRSI | 121 | O43692 | |
| ELSRLAGQIRRLYGS | 141 | Q6PF06 | |
| YLALRSRSGRSIING | 451 | Q6ZMP0 | |
| LRGSTRLTLCGSNFY | 581 | Q04912 | |
| RSLYSLGGVRSLNVA | 46 | Q3SY84 | |
| GSRSLYSLGGNRRIS | 46 | Q7RTS7 | |
| GGLLRQTSRTTTAVY | 421 | P59046 | |
| IELSLYRNALGSRGV | 716 | P59046 | |
| LGRGSRLLCETSLGY | 2071 | Q6PIF6 | |
| SATYIRRALGQGQSV | 201 | Q96T66 |